Tan DS - Search Results

1

New perspectives on molecular targeted therapy in ovarian clear cell carcinoma.

Tan DS, Miller RE, Kaye SB. Tan DS, et al. Br J Cancer. 2013 Apr 30;108(8):1553-9. doi: 10.1038/bjc.2013.126. Epub 2013 Apr 4. Br J Cancer. 2013. PMID: 23558892 Free PMC article. Review.

2

Ovarian clear cell adenocarcinoma: a continuing enigma.

Tan DS, Kaye S. Tan DS, et al. J Clin Pathol. 2007 Apr;60(4):355-60. doi: 10.1136/jcp.2006.040030. Epub 2006 Oct 3. J Clin Pathol. 2007. PMID: 17018684 Free PMC article. Review.

3

Mechanisms of transcoelomic metastasis in ovarian cancer.

Tan DS, Agarwal R, Kaye SB. Tan DS, et al. Lancet Oncol. 2006 Nov;7(11):925-34. doi: 10.1016/S1470-2045(06)70939-1. Lancet Oncol. 2006. PMID: 17081918 Review.

4

Ovarian cancer: can we reverse drug resistance?

Tan DS, Ang JE, Kaye SB. Tan DS, et al. Adv Exp Med Biol. 2008;622:153-67. doi: 10.1007/978-0-387-68969-2_13. Adv Exp Med Biol. 2008. PMID: 18546626 Review. No abstract available.

5

"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.

Tan DS, Rothermundt C, Thomas K, Bancroft E, Eeles R, Shanley S, Ardern-Jones A, Norman A, Kaye SB, Gore ME. Tan DS, et al. J Clin Oncol. 2008 Dec 1;26(34):5530-6. doi: 10.1200/JCO.2008.16.1703. Epub 2008 Oct 27. J Clin Oncol. 2008. PMID: 18955455

6

PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.

Tan DS, Lambros MB, Rayter S, Natrajan R, Vatcheva R, Gao Q, Marchiò C, Geyer FC, Savage K, Parry S, Fenwick K, Tamber N, Mackay A, Dexter T, Jameson C, McCluggage WG, Williams A, Graham A, Faratian D, El-Bahrawy M, Paige AJ, Gabra H, Gore ME, Zvelebil M, Lord CJ, Kaye SB, Ashworth A, Reis-Filho JS. Tan DS, et al. Clin Cancer Res. 2009 Apr 1;15(7):2269-80. doi: 10.1158/1078-0432.CCR-08-2403. Epub 2009 Mar 17. Clin Cancer Res. 2009. PMID: 19293255

7

Weekly paclitaxel in the treatment of recurrent ovarian cancer.

Baird RD, Tan DS, Kaye SB. Baird RD, et al. Among authors: tan ds. Nat Rev Clin Oncol. 2010 Oct;7(10):575-82. doi: 10.1038/nrclinonc.2010.120. Epub 2010 Aug 3. Nat Rev Clin Oncol. 2010. PMID: 20683437 Review.

8

Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas.

Tan DS, Iravani M, McCluggage WG, Lambros MB, Milanezi F, Mackay A, Gourley C, Geyer FC, Vatcheva R, Millar J, Thomas K, Natrajan R, Savage K, Fenwick K, Williams A, Jameson C, El-Bahrawy M, Gore ME, Gabra H, Kaye SB, Ashworth A, Reis-Filho JS. Tan DS, et al. Clin Cancer Res. 2011 Mar 15;17(6):1521-34. doi: 10.1158/1078-0432.CCR-10-1688. Clin Cancer Res. 2011. PMID: 21411445

9

Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancer.

Tan DS, Yap TA, Hutka M, Roxburgh P, Ang J, Banerjee S, Grzybowska E, Gourley C, Gore ME, Kaye SB. Tan DS, et al. Eur J Cancer. 2013 Apr;49(6):1246-53. doi: 10.1016/j.ejca.2012.11.016. Epub 2012 Dec 19. Eur J Cancer. 2013. PMID: 23265709

10

Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

Kipps E, Tan DS, Kaye SB. Kipps E, et al. Among authors: tan ds. Nat Rev Cancer. 2013 Apr;13(4):273-82. doi: 10.1038/nrc3432. Epub 2013 Feb 21. Nat Rev Cancer. 2013. PMID: 23426401 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

536 results

Search Page

Filters